Journals and Databases

Start a new search

Healthcare Databases Advanced Search | Help

 

Searched: Antiretroviral Therapy, Highly Active. Total records matched: 3083

Resources searched: MEDLINE from PubMed

  1. 1. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.

    Author(s): Fokouo JV, Vokwely JE, Noubiap JJ, Nouthe BE, Zafack J, Minka Ngom ES, Dalil AB, Ngo Nyeki AR, Bengono G, Njock R

    Citation: JAMA otolaryngology-- head & neck surgery, 05 March 2015, 2168-6181

    Publication Date: 05 March 2015

    Source: MEDLINE from PubMed

  2. 2. Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.

    Author(s): Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C

    Citation: Patient related outcome measures, 2015(53-60),

    Publication Date: 2015

    Source: MEDLINE from PubMed

  3. 3. Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada.

    Author(s): Lourenço L, Samji H, Nohpal A, Chau W, Colley G, Lepik K, Barrios R, Lima V, Hogg R, Montaner J, Kesselring S, Moore D

    Citation: HIV medicine, 27 February 2015, 1464-2662

    Publication Date: 27 February 2015

    Source: MEDLINE from PubMed

  4. 4. Thymic function over one-year highly active antiretroviral therapy (HAART) in HIV-infected Thai patients with different immune recovery.

    Author(s): Kingkeow D, Srithep S, Praparattanapan J, Supparatpinyo K, Pornprasert S

    Citation: Japanese journal of infectious diseases, 13 February 2015, 1344-6304

    Publication Date: 13 February 2015

    Source: MEDLINE from PubMed

  5. 5. Fibrinolytic changes in pregnant women on highly active antiretroviral therapy.

    Author(s): Osime OE, Ese-Onakewhor JU, Kolade SO

    Citation: Saudi medical journal, February 2015, vol./is. 36/2(200-3), 0379-5284

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  6. 6. The effect of highly active antiretroviral therapy on the prevalence of oral manifestation in human immunodeficiency virus-infected patients in Karnataka, India.

    Author(s): Patil N, Chaurasia VR, Babaji P, Ramesh D, Jhamb K, Sharma AM

    Citation: European journal of dentistry, January 2015, vol./is. 9/1(47-52), 1305-7456

    Publication Date: January 2015

    Source: MEDLINE from PubMed

  7. 7. CD4 Count is Still a Valid Indicator of Outcome in HIV-Infected Patients Undergoing Major Abdominal Surgery in the Era of Highly Active Antiretroviral Therapy.

    Author(s): Chichom-Mefire A, Azabji-Kenfack M, Atashili J

    Citation: World journal of surgery, 07 February 2015, 0364-2313

    Publication Date: 07 February 2015

    Source: MEDLINE from PubMed

  8. 8. CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.

    Author(s): James A, Oluwatosin B, Njideka G, Babafemi, Benjamin OG, Olufemi D, Leo R, Folorunso I, Phylis, Olusina O

    Citation: Oral surgery, December 2014, vol./is. 7/Suppl 1(102-106), 1752-2471

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  9. 9. Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS Patient.

    Author(s): Nelwan EJ

    Citation: Acta medica Indonesiana, October 2014, vol./is. 46/4(273-4), 0125-9326

    Publication Date: October 2014

    Source: MEDLINE from PubMed

  10. 10. Gender Differences in Health Related Quality of Life among People Living with HIV on Highly Active Antiretroviral Therapy in Mekelle Town, Northern Ethiopia.

    Author(s): Tesfay A, Gebremariam A, Gerbaba M, Abrha H

    Citation: BioMed research international, 2015(516369), 2314-6133

    Publication Date: 2015

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

    Available in fulltext at EBSCOhost

  11. 11. [Epidemiological characteristics of HIV/AIDS patients newly received highly active antiretroviral therapy during 2005-2013 in Jiangsu province].

    Author(s): Qiu T, Ding P, Liu X, Xu J, Guo H, Fu G, Xu X, Huan X

    Citation: Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, December 2014, vol./is. 35/12(1320-3), 0254-6450

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  12. 12. Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral Therapy-Naive Women With HIV: A Cohort Study.

    Author(s): Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R

    Citation: Annals of internal medicine, 20 January 2015, vol./is. 162/2(90-9), 0003-4819

    Publication Date: 20 January 2015

    Source: MEDLINE from PubMed

  13. 13. Clinical Challenges of Thyroid Eye Disease in HIV-Positive Patients on Highly Active Antiretroviral Therapy.

    Author(s): Edmunds MR, Mellington F, Ford RL, Torlinska B, Manavi K, Boelaert K

    Citation: The Journal of clinical endocrinology and metabolism, March 2015, vol./is. 100/3(779-87), 0021-972X

    Publication Date: March 2015

    Source: MEDLINE from PubMed

  14. 14. [Analysis of the five-year effectiveness of highly active antiretroviral therapy among 200 HIV/AIDS patients in Jiangsu province].

    Author(s): Qiu T, Ding P, Liu X, Guo H, Fu G, Xu X, Huan X, Yang H

    Citation: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], November 2014, vol./is. 48/11(947-52), 0253-9624

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  15. 15. Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.

    Author(s): Farhoudi M, Khalili H, Karimzadeh I, Abbasian L

    Citation: Expert opinion on drug metabolism & toxicology, 05 January 2015(1-9), 1742-5255

    Publication Date: 05 January 2015

    Source: MEDLINE from PubMed

  16. 16. Outcome of highly active antiretroviral therapy in HIV- infected Indian children.

    Author(s): Mukherjee A, Shah N, Singh R, Vajpayee M, Kabra SK, Lodha R

    Citation: BMC infectious diseases, 24 December 2014, vol./is. 14/1(2),

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  17. 17. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.

    Author(s): Arirachakaran P, Poovorawan Y, Dahlén G

    Citation: Journal of investigative and clinical dentistry, 24 December 2014, 2041-1618

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

  18. 18. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.

    Author(s): Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S

    Citation: Journal of the International Association of Providers of AIDS Care, July 2014, vol./is. 13/4(346-52), 2325-9574

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  19. 19. Retraction: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

    Citation: BMC research notes, 25 November 2014(868),

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  20. 20. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy.

    Author(s): Sede M, Jones LR, Moretti F, Laufer N, Quarleri J

    Citation: Virology, December 2014(19-28), 0042-6822

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  21. 21. Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy.

    Author(s): Nelson MD, Szczepaniak LS, LaBounty TM, Szczepaniak E, Li D, Tighiouart M, Li Q, Dharmakumar R, Sannes G, Fan Z, Yumul R, Hardy WD, Hernandez Conte A

    Citation: JACC. Cardiovascular imaging, November 2014, vol./is. 7/11(1175-7), 1936-878X

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  22. 22. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.

    Author(s): Chou CC, Tsai HC, Wu KS, Sy CL, Chen JK, Chen YS, Lee SS

    Citation: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 01 November 2014, 1684-1182

    Publication Date: 01 November 2014

    Source: MEDLINE from PubMed

  23. 23. Efficacy of generic highly active antiretroviral therapy in HIV-1 infected individuals in Nigeria.

    Author(s): Adewumi OM, Odaibo GN, Olaleye OD

    Citation: Journal of immunoassay & immunochemistry, 01 December 2014, 1532-1819

    Publication Date: 01 December 2014

    Source: MEDLINE from PubMed

  24. 24. HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy.

    Author(s): Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W

    Citation: AIDS research and human retroviruses, 25 November 2014, 0889-2229

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

  25. 25. HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy.

    Author(s): Costiniuk CT, Jenabian MA

    Citation: AIDS patient care and STDs, February 2015, vol./is. 29/2(55-68), 1087-2914

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  26. 26. Short Communication: Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery.

    Author(s): Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL

    Citation: AIDS research and human retroviruses, February 2015, vol./is. 31/2(208-16), 0889-2229

    Publication Date: February 2015

    Source: MEDLINE from PubMed

  27. 27. Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor.

    Author(s): Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, Sotomayor de Zavaleta M, Olvera-Posada D, Sierra-Madero JG, Arreguin-Camacho LO, Castillejos-Molina RA

    Citation: Sexual medicine, April 2014, vol./is. 2/1(24-30),

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  28. 28. Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review.

    Author(s): Katusiime C, Ocama P, Kambugu A

    Citation: African health sciences, September 2014, vol./is. 14/3(679-81), 1680-6905

    Publication Date: September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  29. 29. Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART).

    Author(s): Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP

    Citation: AIDS and behavior, 24 October 2014, 1090-7165

    Publication Date: 24 October 2014

    Source: MEDLINE from PubMed

  30. 30. The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in maiduguri, northeastern Nigeria.

    Author(s): Wakawa IA, Said JM, Abba WM, Shehu S, Rabbebe IB, Beida O

    Citation: Indian journal of psychological medicine, October 2014, vol./is. 36/4(408-17), 0253-7176

    Publication Date: October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  31. 31. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.

    Author(s): Tesfaye Z, Enawgaw B

    Citation: BMC research notes, 22 October 2014(745),

    Publication Date: 22 October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  32. 32. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

    Author(s): Bhutia E, Hemal A, Yadav TP, Ramesh KL

    Citation: African health sciences, June 2014, vol./is. 14/2(408-13), 1680-6905

    Publication Date: June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  33. 33. Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria.

    Author(s): Onyedum CC, Young EE, Iroezindu MO, Chukwuka CJ, Nwagha UI

    Citation: Indian journal of endocrinology and metabolism, September 2014, vol./is. 18/5(631-6), 2230-8210

    Publication Date: September 2014

    Source: MEDLINE from PubMed

  34. 34. Influence of highly-active antiretroviral therapy on the subgingival biofilm in HIV-infected patients.

    Author(s): Jordan RA, Lucaciu A, Zimmer S

    Citation: Journal of investigative and clinical dentistry, 06 October 2014, 2041-1618

    Publication Date: 06 October 2014

    Source: MEDLINE from PubMed

  35. 35. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.

    Author(s): Duro M, Rebelo I, Barreira S, Sarmento-Castro R, Medeiros R, Almeida C

    Citation: International journal of STD & AIDS, 02 October 2014, 0956-4624

    Publication Date: 02 October 2014

    Source: MEDLINE from PubMed

  36. 36. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.

    Author(s): Ortega L, Cooper CJ, Otoukesh S, Mojtahedzadeh M, Didia CS, Torabi A, Nahleh Z

    Citation: Rare tumors, 30 July 2014, vol./is. 6/3(5480), 2036-3605

    Publication Date: 30 July 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  37. 37. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy.

    Author(s): Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, Vlahov D, Plankey MW

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(508-13), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  38. 38. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia.

    Author(s): Eshetu A, Tsegaye A, Petros B

    Citation: Biological trace element research, December 2014, vol./is. 162/1-3(106-12), 0163-4984

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  39. 39. Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy.

    Author(s): Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(493-8), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  40. 40. Vitamin E concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.

    Author(s): Itinoseki Kaio DJ, Rondó PH, Luzia LA, Souza JM, Firmino AV, Santos SS

    Citation: Nutrients, 15 September 2014, vol./is. 6/9(3641-52),

    Publication Date: 15 September 2014

    Source: MEDLINE from PubMed

  41. 41. Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern Nigeria.

    Author(s): Okafor I, Ugwu E, Obi S, Odugu B

    Citation: Annals of medical and health sciences research, July 2014, vol./is. 4/4(615-8), 2141-9248

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  42. 42. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.

    Author(s): Zhyvytsia D

    Citation: Georgian medical news, July 2014(69-74), 1512-0112

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  43. 43. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.

    Author(s): Kyeyune R, Saathoff E, Ezeamama AE, Löscher T, Fawzi W, Guwatudde D

    Citation: BMC infectious diseases, 10 September 2014(496),

    Publication Date: 10 September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  44. 44. High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.

    Author(s): Lumley S, Madge S, Nugent D, Ainsworth J, Dervisevic S, Schmitt C, Schulz TF, Johnson MA, Cwynarski K, Webster DP

    Citation: AIDS (London, England), 17 July 2014, vol./is. 28/11(1698-700), 0269-9370

    Publication Date: 17 July 2014

    Source: MEDLINE from PubMed

  45. 45. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy-era. A literature analysis.

    Author(s): Gaitán-Cepeda LA, Sánchez-Vargas O, Castillo N

    Citation: International journal of STD & AIDS, 25 August 2014, 0956-4624

    Publication Date: 25 August 2014

    Source: MEDLINE from PubMed

  46. 46. Adherence to highly active antiretroviral therapy and associated factors among children at the University of Gondar Hospital and Gondar Poly Clinic, Northwest Ethiopia: a cross-sectional institutional based study.

    Author(s): Dachew BA, Tesfahunegn TB, Birhanu AM

    Citation: BMC public health, 26 August 2014(875),

    Publication Date: 26 August 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  47. 47. Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy.

    Author(s): Eichler K, Bickel T, Klauke S, Eisen J, Vogl T, Zangos S

    Citation: International journal of STD & AIDS, 18 August 2014, 0956-4624

    Publication Date: 18 August 2014

    Source: MEDLINE from PubMed

  48. 48. Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages.

    Author(s): Cribbs SK, Lennox J, Caliendo AM, Brown LA, Guidot DM

    Citation: AIDS research and human retroviruses, January 2015, vol./is. 31/1(64-70), 0889-2229

    Publication Date: January 2015

    Source: MEDLINE from PubMed

  49. 49. The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS.

    Author(s): Zheng Y, Zhou H, He Y, Chen Z, He B, He M

    Citation: AIDS research and human retroviruses, December 2014, vol./is. 30/12(1197-202), 0889-2229

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  50. 50. Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis.

    Author(s): Liu H, Ma Y, Su Y, Smith MK, Liu Y, Jin Y, Gu H, Wu J, Zhu L, Wang N

    Citation: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 November 2014, vol./is. 59/10(1495-502), 1058-4838

    Publication Date: 15 November 2014

    Source: MEDLINE from PubMed


Results Selected
No results selected.

Output Format
Choose output document format.
Display Format
Choose output fields.
Actions
Display, save or email results with selected fields and output formats.